List of redirects

Showing below up to 50 results in range #52,811 to #52,860.

52811. The Living Guidelines: Chronic Stable Angina Pectoris Angiotensin Receptor Blockers Therapy View the Current CLASS IIb Guidelines → Chronic stable angina secondary prevention
52812. The Living Guidelines: Chronic Stable Angina Pectoris Antiplatelets/Anticoagulants Therapy View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52813. The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies View the Current CLASS IIa Guidelines → Chronic stable angina secondary prevention
52814. The Living Guidelines: Chronic Stable Angina Pectoris Beneficial Lipid Management Strategies View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52815. The Living Guidelines: Chronic Stable Angina Pectoris Beta Blockers Therapy View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52816. The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Suggest Revisions to the CLASS II Guidelines → The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management Suggest Revisions to the CLASS I Guidelines
52817. The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS IIa Guidelines → Chronic stable angina secondary prevention
52818. The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS IIb Guidelines → Chronic stable angina secondary prevention
52819. The Living Guidelines: Chronic Stable Angina Pectoris General Considerations for Lipid Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52820. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Blood Pressure Control View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52821. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Diabetes Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52822. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management View the Current CLASS IIa Guidelines → Chronic stable angina secondary prevention
52823. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for LDL-C, HDL-C and Triglycerides Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52824. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity View the Current CLASS IIb Guidelines → Chronic stable angina secondary prevention
52825. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Physical Activity View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52826. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Smoking Cessation View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52827. The Living Guidelines: Chronic Stable Angina Pectoris Recommendations for Weight Management View the Current CLASS I Guidelines → Chronic stable angina secondary prevention
52828. The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS III Guidelines → Atrial fibrillation cardioversion
52829. The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS IIa Guidelines → Atrial fibrillation cardioversion
52830. The Living Guidelines: Direct-current cardioversion of atrial fibrillation and atrial flutter: View the Current CLASS I Guidelines → Atrial fibrillation cardioversion
52831. The Living Guidelines: End-of-life Considerations. View the Current CLASS III Guidelines → Congestive heart failure end-of-life considerations
52832. The Living Guidelines: End-of-life Considerations. View the Current CLASS I Guidelines → Congestive heart failure end-of-life considerations
52833. The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS III Guidelines → Congestive heart failure implementation of practice guidelines
52834. The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS IIa Guidelines → Congestive heart failure implementation of practice guidelines
52835. The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS IIb Guidelines → Congestive heart failure implementation of practice guidelines
52836. The Living Guidelines: Implementation of Practice Guidelines. View the Current CLASS I Guidelines → Congestive heart failure implementation of practice guidelines
52837. The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS III Guidelines → Congestive heart failure clinical assessment
52838. The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure clinical assessment
52839. The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIb Guidelines → Congestive heart failure clinical assessment
52840. The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure clinical assessment
52841. The Living Guidelines: Maintenance of sinus rhythm: View the Current CLASS III Guidelines → Atrial fibrillation maintenance of sinus rhythm
52842. The Living Guidelines: Maintenance of sinus rhythm: View the Current CLASS IIa Guidelines → Atrial fibrillation maintenance of sinus rhythm
52843. The Living Guidelines: Maintenance of sinus rhythm: View the Current CLASS I Guidelines → Atrial fibrillation maintenance of sinus rhythm
52844. The Living Guidelines: Patients at High Risk for Developing Heart Failure. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
52845. The Living Guidelines: Patients at High Risk for Developing Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
52846. The Living Guidelines: Patients at High Risk for Developing Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients at high risk for developing heart failure (Stage A)
52847. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
52848. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
52849. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
52850. The Living Guidelines: Patients with Cardiac Structural Abnormalities or Remodeling who have not Developed Heart Failure Symptoms. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)
52851. The Living Guidelines: Patients with Heart Failure and Normal LVEF. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
52852. The Living Guidelines: Patients with Heart Failure and Normal LVEF. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
52853. The Living Guidelines: Patients with Heart Failure and Normal LVEF. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)
52854. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
52855. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
52856. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS IIb Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
52857. The Living Guidelines: Patients with Heart Failure who have Concomitant Disorders. View the Current CLASS I Guidelines → Congestive heart failure treatment of patients who have concomitant disorders
52858. The Living Guidelines: Patients with Pulmonary Hypertension: View the Current CLASS III Guidelines → Atrial fibrillation pulmonary diseases
52859. The Living Guidelines: Patients with Pulmonary Hypertension: View the Current CLASS I Guidelines → Atrial fibrillation pulmonary diseases
52860. The Living Guidelines: Patients with Reduced LVEF. View the Current CLASS III Guidelines → Congestive heart failure treatment of patients with current or prior symptoms of heart failure (Stage C)